Meghan Good

Title: The Innovative Contributions of Meghan Good

Introduction

Meghan Good is a notable inventor based in London, GB. She has made significant strides in the field of pharmaceutical formulations, particularly focusing on innovative methods for drug delivery. Her work has the potential to impact the treatment of psychiatric and neurological disorders.

Latest Patents

Meghan Good holds a patent for "Injectable and inhalable formulations." This invention relates to aqueous pharmaceutical formulations that comprise a salt of an optionally substituted dimethyltryptamine compound and water. The formulations are designed with a pH ranging from 5 to 6.5 and a concentration of about 10 mg/ml or greater as the freebase equivalent. These formulations can be used in psychedelic-assisted therapy and are suitable for both intramuscular injection and nebulized inhalation, demonstrating stability and clinical acceptability.

Career Highlights

Meghan Good is currently associated with Cybin UK Ltd, where she continues to develop her innovative ideas. Her work is at the forefront of research in psychedelic therapy, contributing to advancements in mental health treatment.

Collaborations

Meghan collaborates with notable colleagues such as Peter Rands and Carol Routledge, enhancing the research and development efforts at Cybin UK Ltd.

Conclusion

Meghan Good's contributions to pharmaceutical formulations and her innovative approach to drug delivery highlight her importance in the field of mental health treatment. Her work is paving the way for new therapeutic options that could benefit many individuals.